HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
HTG Molecular Diagnostics (HTGM) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $10.39 M
According to HTG Molecular Diagnostics 's latest financial reports the company's total liabilities are $10.39 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
HTG Molecular Diagnostics - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $12.38 M | -38.26% |
| 2021-12-31 | $20.06 M | -3.15% |
| 2020-12-31 | $20.71 M | -2.06% |
| 2019-12-31 | $21.14 M | -6.74% |
| 2018-12-31 | $22.67 M | -6.73% |
| 2017-12-31 | $24.31 M | 1.12% |
| 2016-12-31 | $24.04 M | 6.62% |
| 2015-12-31 | $22.55 M | -31.17% |
| 2014-12-31 | $32.76 M | 22.06% |
| 2013-12-31 | $26.84 M | 0.58% |
| 2012-12-31 | $26.69 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.13 B | 1,211.88% | 🇺🇸 USA |
 Affimed
AFMD | $43.5 M | 318.67% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | $8.28 M | -20.28% | 🇺🇸 USA |